TIGERMED: JPMorgan Chase & Co. Disposes of Shares, Long Position Falls to 18.96%

HK Disclosure11-06

JPMorgan Chase & Co. sold 77,022 shares of TIGERMED (03347) off-exchange at an average of HKD 37.9266 per share on November 2, 2026, involving about HKD 2.92 million, an off-exchange transaction settled in cash that was not matched on the SEHK open market and therefore not a direct secondary-market dealing.

Prior to the disposal, JPMorgan Chase & Co.’s long position in TIGERMED was 23.43 million shares, representing 19.02%; following the disposal, the holding changed to 23.35 million shares, with the long position ratio falling to 18.96%.

Source: Hong Kong Exchanges and Clearing Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment